Gender differences in the outcome of interventional cardiac procedures

Italian Heart Journal

Volumn 4, Issue 8, 2003, Pages 522-527

  Presbitero, Patrizia ^a   Carcagnì, Addolorata ^a  

^a HUMANITAS CLINICAL AND RESEARCH CENTER   (Italy)

Author keywords

Coronary angioplasty; Sex

Indexed keywords

ACUTE DISEASE; COMPARATIVE STUDY; FEMALE; HEART INFARCTION; HUMAN; MALE; MIDDLE AGED; MORTALITY; RESTENOSIS; REVIEW; SEX DIFFERENCE; STENT; TRANSLUMINAL CORONARY ANGIOPLASTY; TREATMENT OUTCOME;

ACUTE DISEASE; ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; CORONARY RESTENOSIS; FEMALE; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; SEX FACTORS; STENTS; TREATMENT OUTCOME;

EID: 1542680141     PISSN: 1129471X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (47)

1. Wenger NK, Speroff L, Packard B. Cardiovascular health and disease in women. In: Proceedings of the National Heart, Lung and Blood Institute Conference. Greenwich, CT: Le Jacq Communication, 1993: 103-4.
2. Cowley MJ, Mullin SM, Kelsey SK, et al. Sex differences in early and long-term results of coronary angioplasty in the NHLBI PTCA Registry. Circulation 1985; 71: 90-7.
3. Kelsey SF, James M, Holubkov AL, Holubkov R, Cowley MJ, Detre KM. Results of percutaneous transluminal coronary angioplasty in women: 1985-1986 National Heart, Lung and Blood Institute's Coronary Angioplasty Registry. Circulation 1993; 87: 720-7.
4. Malenka DJ, O'Connor GT, Quinton H, Wennberg D, Robb JF. Differences in outcomes between women and men associated with percutaneous transluminal coronary angioplasty. A regional prospective study of 13 061 procedures. Northern New England Cardiovascular Disease Study Group. Circulation 1996; 94 (Suppl): II99-II104.
5. Arnold AM, Mick MJ, Piedmonte MR, Simpfendorfer C. Gender differences for coronary angioplasty. Am J Cardiol 1994; 74: 18-21.
6. Kahn JK, Rutherford BD, McConahay DR, et al. Comparison of procedural results and risks of coronary angioplasty in men and women for conditions other than acute myocardial infarction. Am J Cardiol 1992; 69: 1241-2.
7. Bell MR, Holmes DR Jr, Berger PB, Garratt KN, Bailey KR, Gersh BJ. The changing in-hospital mortality of women undergoing percutaneous transluminal coronary angioplasty. JAMA 1993; 269: 2091-5.
8. Williams DO, Holubkov R, Yeh W, et al. Percutaneous coronary intervention in the current era compared with 1985-1986: the National Heart, Lung, and Blood Institute Registries. Circulation 2000; 102: 2945-51.
9. Weinstraub WS, Wenger NK, Kosinski AS, et al. Percutaneous transluminal coronary angioplasty in women compared with men. J Am Coll Cardiol 1994; 24: 81-90.
10. McEniery PT, Hollman J, Knezinek V, et al. Comparative safety and efficacy of percutaneous transluminal coronary angioplasty in men and in women. Cathet Cardiovasc Diagn 1987; 13: 364-71.
11. Bell MR, Grill DE, Garratt KN, Berger PB, Gersh BJ, Holmes DR Jr. Long-term outcome of women compared with men after successful coronary angioplasty. Circulation 1995; 91: 2876-81.
12. Robertson T, Kennard ED, Mehta S, et al. Influence of gender on in-hospital clinical and angiographic outcomes and on one-year follow-up in the New Approaches to Coronary Intervention (NACI) registry. Am J Cardiol 1997; 80: 26K-39K.
13. Jacobs AK, Kelsey SF, Yeh W, et al. Documentation of decline in morbidity in women undergoing coronary angioplasty (a report from the 1993-94 NHLBI Percutaneous Transluminal Coronary Angioplasty Registry). National Heart, Lung, and Blood Institute. Am J Cardiol 1997; 80: 979-84.
14. Cantor WJ, Miller JM, Hellkamp AS, et al. Role of target vessel size and body surface area on outcomes after percutaneous coronary interventions in women. Am Heart J 2002; 144: 297-302.
15. Tenaglia AN, Fortin DF, Califf RM, et al. Predicting the risk of abrupt vessel closure after angioplasty in an individual patient. J Am Coll Cardiol 1994; 24: 1004-11.
16. Carcagnì A, Camellini M, Maiello L, et al. Percutaneous transluminal coronary revascularization in women: higher risk dissection and need for stenting. Ital Heart J 2000; 1: 536-41.
17. Tan K, Sulke N, Taub N, Sowton E. Clinical and lesion morphologic determinants of coronary success and complications: current experience. J Am Coll Cardiol 1995; 25: 855-65.
18. Hermans WR, Foley DP, Rensing BJ, et al. Usefulness of quantitative and qualitative angiographic lesion morphology, and clinical characteristics in predicting major adverse cardiac events during and after native coronary balloon angioplasty. CARPORT and MERCATOR Study Groups. Am J Cardiol 1993; 72: 14-20.
19. Raymenants E, Bhandari S, Stammen F, et al. Effects of angioplasty balloon material and lesion characteristics on the incidence of coronary dissection in 2150 dilated lesions. (abstr) J Am Coll Cardiol 1993; 21: 291A.
20. Roubin GS, Lin S, Niederman A, et al. Clinical and anatomic descriptors for a major complication following PTCA. J Am Coll Cardiol 1987; 9: 20-5.
21. Ellis SG, Roubin GS, King SB III, et al. Angiographic and clinical predictors of acute closure after native vessel coronary angioplasty. Circulation 1988; 77: 372-9.
22. Lincoff AM, Topol EJ. Abrupt vessel closure. In: Topol EJ, ed. Textbook of interventional cardiology. Philadelphia, PA: WB Saunders, 1994: 207-30.
23. Van Belle E, Abolmaali K, Bauters C, McFadden EP, Lablanche JM, Bertrand ME. Restenosis, late vessel occlusion and left ventricular function six months after balloon angioplasty in diabetic patients. J Am Coll Cardiol 1999; 34: 476-85.
24. Mautner SL, Lin F, Mautner GC, Roberts WC. Comparison in women versus men of composition of atherosclerotic plaques in native coronary arteries and in saphenous veins used as aortocoronary conduits. J Am Coll Cardiol 1993; 21: 1312-8.
25. Gowda MS, Vacek JL, Hallas D. Gender related risk factors and outcomes for non-Q wave myocardial infarction patients receiving in-hospital PTCA. J Invasive Cardiol 1999; 11: 121-6.
26. Mehilli J, Kastrati A, Dirschinger J, Bollwein H, Neumann FJ, Schomig A. Differences in prognostic factors and outcomes between women and men undergoing coronary artery stenting. JAMA 2000; 284: 1799-805.
27. Vaccarino V, Parsons L, Every NR, Barron HV, Krumholz HM. Sex-based differences in early mortality after myocardial infarction. National Registry of Myocardial Infarction 2 Participants. N Engl J Med 1999; 341: 217-25.
28. Vaccarino V, Abramson JL, Veledar E, Weintraub WS. Sex differences in hospital mortality after coronary artery by-pass surgery: evidence for a higher mortality in younger women. Circulation 2002; 105: 1176-81.
29. Cho L, Topol EJ, Balog C, et al. Clinical benefit of glyco-protein IIb/ IIIa blockade with abciximab is independent of gender: pooled analysis from EPIC, EPILOG and EPISTENT trials. Evaluation of 7E3 for the Prevention of Ischemic Complications. Evaluation in Percutaneous Trans-luminal Coronary Angioplasty to Improve Long-Term Outcome with Abciximab GP IIb/IIIa Blockade. Evaluation of Platelet IIb/IIIa Inhibitor for Stent. J Am Coll Cardiol 2000; 36: 381-6.
30. Marso SP, Lincoff AM, Ellis SG, et al. Optimizing the percutaneous interventional outcomes for patients with diabetes mellitus: results of the EPISTENT (Evaluation of platelet IIb/IIIa inhibitor for stenting trial) diabetic sub-study. Circulation 1999; 100: 2477-84.
31. Jacobs AK, Kelsey SF, Brooks MM, et al. Better outcome for women compared with men undergoing coronary revascularization: a report from the Bypass Angioplasty Revascularization Investigation (BARI). Circulation 1998; 98: 1279-85.
32. Becker RC, Terrin M, Ross R, et al. Comparison of clinical outcomes for women and men after acute myocardial infarction. The Thrombolysis in Myocardial Infarction Investigators. Ann Intern Med 1994; 120: 638-45.
33. Maynard C, Litwin PE, Martin JS, Weaver WD. Gender differences in the treatment and outcome of acute myocardial infarction. Results from the Myocardial lnfarction Triage and Intervention Registry. Arch Intern Med 1992; 152: 972-6.
34. Lincoff AM, Califf RM, Ellis SG, et al. Thrombolytic therapy for women with myocardial infarction: is there a gender gap? Thrombolysis and Angioplasty in Myocardial Infarction Study Group. J Am Coll Cardiol 1993; 22: 1780-7.
35. Woodfield SL, Lundergan CF, Reiner JS, et al. Gender and acute myocardial infarction: is there a different response to thrombolysis? J Am Coll Cardiol 1997; 29: 35-42.
36. Weaver WD, Simes RJ, Betriu A, et al. Comparison of primary coronary angioplasty and intravenous thrombolytic therapy for acute myocardial infarction: a quantitative review. JAMA 1997; 278: 2093-8.
37. Vacek JL, Rosamond TL, Kramer PH, et al. Sex-related differences in patients undergoing direct angioplasty for acute myocardial infarction. Am Heart J 1993; 126 (Part 1): 521-5.
38. Stone GW, Grines CL, Browne KF, et al. Comparison of in-hospital outcome in men versus women treated by either thrombolytic therapy or primary coronary angioplasty for acute myocardial infarction. Am J Cardiol 1995; 75: 987-92.
39. Brodie BR, Stone GW, Morice MC, et al. Importance of time to reperfusion on outcomes with primary coronary angioplasty for acute myocardial infarction (results from the Stent Primary Angioplasty in Myocardial Infarction Trial). Am J Cardiol 2001; 88: 1085-90.
40. Randomised placebo-controlled and balloon-angioplasty-controlled trial to assess safety of coronary stenting with use of platelet glycoprotein-IIb/IIIa blockade. The EPISTENT Investigators. Evaluation of Platelet IIb/IIIa Inhibitor for Stenting. Lancet 1998; 352: 87-92.
41. Azar RR, Waters DD, McKay RG, et al. Short- and medium-term outcome differences in women and men after primary percutaneous transluminal mechanical revascularization for acute myocardial infarction. Am J Cardiol 2000; 85: 675-9.
42. Heer T, Schiele R, Schneider S, et al. Gender differences in acute myocardial infarction in the era of reperfusion (the MITRA registry). Am J Cardiol 2002; 89: 511-7.
43. Mehilli J, Kastrati A, Dirschinger J, et al. Sex-based analysis of outcome in patients with acute myocardial infarction treated predominantly with percutaneous coronary intervention. JAMA 2002; 287: 210-5.
44. Hannan EL, Racz MJ, Arani DT, Ryan TJ, Walfort G, McCallister BD. Short- and long-term mortality for patients undergoing primary angioplasty for acute myocardial infarction. J Am Coll Cardiol 2000; 36: 1194-201.
45. Wong SC, Sleeper LA, Monrad ES, et al. Absence of gender differences in clinical outcomes in patients with cardiogenic shock complicating acute myocardial infarction. A report from the SHOCK Trial Registry. J Am Coll Cardiol 2001; 38: 1395-401.
46. Moreno R, Lopez-Sendon J, Garcia E, et al. Primary angioplasty reduces the risk of left ventricular free rupture compared with thrombolysis in patients with acute myocardial infarction. J Am Coll Cardiol 2002; 39: 598-603.
47. Angeja BG, Gibson CM, Chin R, et al, for the Participants in the National Registry of Myocardial Infarction 2-3. Predictors of door-to-balloon delay in primary angioplasty. Am J Cardiol 2002; 89: 1156-61.